InvestorsHub Logo

Titan V

11/22/17 10:20 AM

#42072 RE: lasers #42068

Right, even for preclinical studies like ADXS-AMGN neoantigen collaboration, which BTW hasn’t started phase 1 for a long time now. I wonder why.

I think ONCS multigene construct is going to be partnered out sooner or later and it could have significant implications.